glp 1 inhibitor GLP-1 Agonists - What is it? Glucagon-like peptide-1 receptor: mechanisms and
Description
The LEADER trial showed a 13% reduction in major adverse cardiovascular events over 3.5 years
Neurology: Neuroimmunology & Neuroinflammation
[DOI] [PMC free article] [PubMed] [Google Scholar] 34.Novonordisk
144 GLP-1RAs and gastrointestinal cancers GLP-1 and its receptor agonists show some potential in the treatment of gastrointestinal cancers, although this remains an emerging area of research
Conversely, the interplay between metabolic imbalances and inflammatory responses can further exacerbate GM dysbiosis, perpetuating a cycle of mutual exacerbation
He L, Li Q, Yang Y, Li J, Luo W, Huang Y, et al
